MAFB and colitis: As seen in Figure 3C, the reduced levels of Occludin and ZO‐1 caused by DSS were markedly reversed after the treatment of MAFB overexpression, proving that the upregulation of MAFB could inhibit DSS‐induced intestinal barrier impairment in colitis mice.